Stock Movers: Ventyx, Mobileye, and Strategy Discussed

Ventyx Biosciences Acquisition Talks

• 💡 Ventyx Biosciences (VTYX) shares surged nearly 60% in after-hours trading following a Wall Street Journal report.
• 🎯 Eli Lilly is reportedly in advanced talks to acquire Ventyx for over $1 billion, aiming to expand its work in immunology.
• 🌱 Ventyx specializes in developing medications for inflammatory diseases such as Crohn's disease and rheumatoid arthritis.

Mobileye Global Acquires Mentee Robotics

• 🚀 Mobileye Global (MBLY), a self-driving car systems company, is acquiring Israeli startup Mentee Robotics.
• 🤖 The cash-and-stock deal is valued at approximately $900 million and aims to develop humanoid robots.
• 🛠️ Mentee Robotics will also assist Mobileye in automating its factories and manufacturing processes.

MSCI's Decision on Digital Asset Companies

• 📊 MSCI announced it will maintain current index treatment for digital asset treasury companies, including those with over 50% in crypto holdings.
• 💰 This decision allows Strategy (MSTR), which holds over $60 billion in Bitcoin, to remain in MSCI's global benchmarks for now.
• 🔍 MSCI plans to launch a broader consultation on how non-operating companies should be treated in its indexes.
• 📈 Strategy shares saw a rise of around 5% in after-market trading, recovering from a significant slump over the past year.